Qinghai Spring Medicinal Resources Technology Co Ltd (600381) — Cash Flow-to-Debt Ratio
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has a Cash Flow-to-Debt Ratio of -0.18x as of September 2025, meaning its operating cash flow of CN¥-8.22 Million could theoretically repay 0% of its total liabilities (CN¥45.34 Million) in one year. See 600381 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Qinghai Spring Medicinal Resources Technology Co Ltd Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Qinghai Spring Medicinal Resources Technology Co Ltd across 27 annual periods. Also explore Qinghai Spring Medicinal Resources Techn annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Qinghai Spring Medicinal Resources Technology Co Ltd (1999–2025)
Year-by-year debt coverage analysis for Qinghai Spring Medicinal Resources Technology Co Ltd. For market capitalisation and broader financial context, see 600381 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.59x | CN¥-26.41 Million | CN¥44.87 Million | ▼ -193.1% |
| 2024 | 0.63x | CN¥80.97 Million | CN¥128.02 Million | ▲ +143.3% |
| 2023 | 0.26x | CN¥23.92 Million | CN¥91.99 Million | ▲ +121.5% |
| 2022 | -1.21x | CN¥-31.82 Million | CN¥26.30 Million | ▲ +47.7% |
| 2021 | -2.31x | CN¥-63.93 Million | CN¥27.64 Million | ▼ -306.8% |
| 2020 | -0.57x | CN¥-77.95 Million | CN¥137.08 Million | ▲ +95.2% |
| 2019 | -11.74x | CN¥-236.30 Million | CN¥20.14 Million | ▼ -236.1% |
| 2018 | -3.49x | CN¥-183.97 Million | CN¥52.68 Million | ▼ -514.2% |
| 2017 | 0.84x | CN¥95.74 Million | CN¥113.56 Million | ▼ -49.4% |
| 2016 | 1.67x | CN¥344.99 Million | CN¥206.95 Million | ▼ -29.0% |
| 2015 | 2.35x | CN¥832.17 Million | CN¥354.60 Million | ▲ +3049.9% |
| 2014 | -0.08x | CN¥-89.64 Million | CN¥1.13 Billion | ▼ -307.5% |
| 2013 | -0.02x | CN¥-28.09 Million | CN¥1.44 Billion | ▲ +94.7% |
| 2012 | -0.37x | CN¥-701.18 Million | CN¥1.90 Billion | ▼ -338.9% |
| 2011 | 0.15x | CN¥249.98 Million | CN¥1.62 Billion | ▲ +102.9% |
| 2010 | 0.08x | CN¥71.47 Million | CN¥938.58 Million | ▲ +2.2% |
| 2009 | 0.07x | CN¥39.16 Million | CN¥525.60 Million | ▲ +110.7% |
| 2008 | 0.04x | CN¥20.83 Million | CN¥589.02 Million | ▲ +257.7% |
| 2007 | 0.01x | CN¥7.00 Million | CN¥707.61 Million | ▼ -60.4% |
| 2006 | 0.02x | CN¥21.57 Million | CN¥863.38 Million | ▼ -83.9% |
| 2005 | 0.16x | CN¥162.12 Million | CN¥1.05 Billion | ▲ +461.1% |
| 2004 | 0.03x | CN¥33.83 Million | CN¥1.22 Billion | ▲ +1430.8% |
| 2003 | 0.00x | CN¥1.43 Million | CN¥789.85 Million | ▼ -95.2% |
| 2002 | 0.04x | CN¥15.54 Million | CN¥415.90 Million | ▲ +193.0% |
| 2001 | -0.04x | CN¥-10.64 Million | CN¥264.94 Million | ▼ -267.0% |
| 2000 | 0.02x | CN¥4.52 Million | CN¥187.91 Million | ▼ -95.6% |
| 1999 | 0.55x | CN¥70.28 Million | CN¥128.04 Million | — |